Grant: Engage Grants Program
University of Saskatchewan
$25,000.00
Developing a multi-species biofilm model for testing novel antimicrobials
FY 2016-17
Summary
With an increase in the number of pathogenic bacteria developing resistance to multiple antibiotics, alternative technologies are needed to address this problem. Bacteria also commonly form biofilms, a mode of growth where cells aggregate and become embedded in a protective extracellular matrix, making them even more difficult to treat. It is estimated that up to 40% of human diseases are biofilm-related. SterileCare Inc., a young Canadian biotechnology company, has developed an innovative non-antibiotic antimicrobial agent that is effective against hard to treat bacteria such as MRSA, VRE and Pseudomonas. Clinically relevant conditions of biofilm reveal the presence of a complex mixture of Gram-positive and Gram-negative bacteria and fungi within these biofilms, conferring important survival information to each other. Sterile Care Inc. would like to establish a research partnership with Dr. White and VIDO-InterVac to develop a multi-species biofilm model that more closely represents in vivo conditions. We will use this biofilm model to document the synergistic effects between microorganisms and challenge with the antimicrobial agent at different concentrations and in combination with other antimicrobials. In line with global Antibiotic Stewardship efforts and active search for an effective alternative to antibiotics, SterileCare Inc. hopes to further develop a powerful agent to treat both human and veterinary conditions associated with biofilms and multidrug resistant microorganisms.
Program
Engage Grants Program
Recipient
Location
Saskatchewan, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
500938-2016
Name nom
White, Aaron
Department département
VIDO-Vaccine and Infectious Disease Organization
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2016
Competition year année de concours
2016
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
505
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Veterinary pharmaceuticals
Area of application fr
Produits pharmaceutiques à usage vétérinaire
Research subject code
5201
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Bacteriology
Research subject fr
Bactériologie
Partie
1
Nb partie
1
Application title
Developing a multi-species biofilm model for testing novel antimicrobials
Keyword
NSERC
Application summary
With an increase in the number of pathogenic bacteria developing resistance to multiple antibiotics, alternative technologies are needed to address this problem. Bacteria also commonly form biofilms, a mode of growth where cells aggregate and become embedded in a protective extracellular matrix, making them even more difficult to treat. It is estimated that up to 40% of human diseases are biofilm-related. SterileCare Inc., a young Canadian biotechnology company, has developed an innovative non-antibiotic antimicrobial agent that is effective against hard to treat bacteria such as MRSA, VRE and Pseudomonas. Clinically relevant conditions of biofilm reveal the presence of a complex mixture of Gram-positive and Gram-negative bacteria and fungi within these biofilms, conferring important survival information to each other. Sterile Care Inc. would like to establish a research partnership with Dr. White and VIDO-InterVac to develop a multi-species biofilm model that more closely represents in vivo conditions. We will use this biofilm model to document the synergistic effects between microorganisms and challenge with the antimicrobial agent at different concentrations and in combination with other antimicrobials. In line with global Antibiotic Stewardship efforts and active search for an effective alternative to antibiotics, SterileCare Inc. hopes to further develop a powerful agent to treat both human and veterinary conditions associated with biofilms and multidrug resistant microorganisms.